GlassScriptPhysician profile
Katie Beth Bieber
NPI 1518340603
$5,415.56
in general payments reported to CMS, 2019-2025
25 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $172 · 2021: $415 · 2022: $3,510 · 2023: $316 · 2024: $498 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,103.75 | 2020-2022 | |
| Abbvie INC. | $490.81 | 2019-2025 | Liletta, Qulipta, Ubrelvy |
| Hologic Sales and Service, LLC | $417.93 | 2019-2025 | Aptima, Acessa Provu System, Novasure |
| Exeltis, USA INC. | $169.68 | 2021-2025 | Slynd |
| Exact Sciences Corporation | $161.66 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Organon LLC | $156.52 | 2021-2025 | Nexplanon, Jada System |
| Mayne Pharma Commercial LLC | $132.82 | 2022-2023 | |
| Astellas Pharma US INC | $82.75 | 2023-2025 | Veozah |
| Aspira Women'S Health INC | $81.75 | 2019-2022 | |
| Alydia Health | $77.96 | 2021 | |
| Myovant Sciences INC. | $67.93 | 2021-2022 | |
| Shield Therapeutics INC | $60.86 | 2023-2025 | Accrufer |
| Agile Therapeutics, INC. | $58.69 | 2021-2022 | |
| Becton, Dickinson and Company | $58.15 | 2024 | Bd Max System, Bd Max Instrument |
| Merck Sharp & Dohme LLC | $47.56 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $46.47 | 2022-2025 | Paragard T 380a |
| Vertex Pharmaceuticals Incorporated | $43.09 | 2024-2025 | |
| Therapeuticsmd, INC. | $33.99 | 2021 | |
| Sanofi Pasteur INC. | $24.56 | 2023 | |
| Novo Nordisk INC | $24.18 | 2025 | Wegovy |
| Amag Pharmaceuticals, INC. | $17.80 | 2019 | |
| Channel Medsystems, INC. | $16.79 | 2023 | |
| Lupin INC. | $14.90 | 2021 | |
| Avion Pharmaceuticals | $12.64 | 2022 | |
| Evofem Biosciences, INC. | $12.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Bieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.